Peter Wolfe - 11 Jul 2025 Form 4 Insider Report for ZyVersa Therapeutics, Inc. (ZVSA)

Role: Chief Financial Officer
Signature: /s/ Stephen C. Glover as Attorney-in-Fact for Peter Wolfe pursuant to Power of Attorney
Issuer symbol: ZVSA
Transactions as of: 11 Jul 2025
Net transactions value: $0
Form type: 4
Filing time: 15 Jul 2025, 16:22:52 UTC
Previous filing: 18 Jul 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Wolfe Peter	Chief Financial Officer	C/O ZYVERSA THERAPEUTICS, INC., 2200 N. COMMERCE PARKWAY, SUITE 208, WESTON	/s/ Stephen C. Glover as Attorney-in-Fact for Peter Wolfe pursuant to Power of Attorney	14 Jul 2025	0001954398

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZVSA	Stock Options	Award	$0	+60,100		$0.000000	60,100	11 Jul 2025	Common Stock	60,100	$0.5900	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options were granted on July 11, 2025, and vest and become exercisable in equal annual installments on the first three anniversaries of the grant date, subject to the Reporting Person's continued service on each such vesting date.